Identification of a transcriptional unit adjacent to the breakpoint in the 14;19 translocation of chronic lymphocytic leukemia
โ Scribed by Timothy W. McKeithan; Hitoshi Ohno; Manuel O. Diaz
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- English
- Weight
- 829 KB
- Volume
- 1
- Category
- Article
- ISSN
- 1045-2257
No coin nor oath required. For personal study only.
โฆ Synopsis
The t( 14; 19)(q32.3;q I 3. I ) is a recurring translocation found in the neoplastic cells of some patients with chronic lymphocytic leukemia (CLL). W e have previously cloned the translocation breakpoint junction present in the leukemic cells from one such patient. In the present study, we have cloned and sequenced the breakpoint junction from a second patient. The breakpoint on chromosome 14 occurs within a switch region upstream of the immunoglobulin heavy chain Cal sequence. W e detected a 2.1-2.3 kb transcript on Northern blots using a probe from chromosome I 9 adjacent to this breakpoint. S, nuclease protection experiments showed that transcription of the gene proceeds in a direction away from the breakpoint junction. This gene (for which we propose the name BCL3) may contribute to the malignant development of B-lymphocytes following the chromosome translocation. If so, it is the first protooncogene identified whose activation is principally associated with CLL.
๐ SIMILAR VOLUMES
The t( 14; 18) chromosomal translocation characteristic of follicular lymphoma (FL) juxtaposes the immunoglobulin heavy chain locus (IGH) and the BCU proto-oncogene. The translocation can be readily detected as a non-germline Not1 fragment resolved by pulsed-field gel electrophoresis. A benefit of t
Deletions of 11q in chronic lymphocytic leukemia (CLL) are usually associated with progressive disease and poor prognosis. A novel translocation within the previously identified 11q minimal region has been defined in a patient with CLL. The breakpoint is between genes POU2AF1 and BTG4. POU2AF1 is a
The genetic basis and molecular pathogenesis of chronic lymphocytic leukemia (CLL) and the molecular mechanisms responsible for its progression remain poorly understood. Here, karyotyping techniques specifically optimized for CLL, comparative genomic hybridization (CGH), and fluorescence in situ hyb
## Abstract In order to identify regulatory genes involved in the development of an apoptosisโresistant phenotype in patients with chemotherapy refractory Bโcell chronic lymphocytic leukemia (BโCLL) expression of apoptosisโregulating genes in BโCLL cells was quantified using cDNA arrays and RTโPCR.
## Abstract We have previously identified 12 surface antigens whose differential expression represented the signature of Bโcell chronic lymphocytic leukemia (BโCLL) subsets with different prognosis. In the present study, expression data for these antigens, as determined in 137 BโCLL cases, all with